Blue Jet Healthcare Ltd
Blue Jet Healthcare Ltd (BLUEJET) last reported results for the quarter ended Jun 2026, with sales of ₹293 crore and net profit of ₹78 crore. The stock last traded at ₹543, a market capitalisation of ₹10,270 crore, on a P/E of 43.7. Over the past 52 weeks the stock has ranged between ₹325 and ₹693. Figures are as of 6 Oct 2026 and are not real time.
Blue Jet Healthcare Ltd share price and key metrics
- Current price
- ₹543
- Market cap
- ₹10,270 cr
- Stock P/E
- 43.7
- Book value
- ₹78.4
- ROE
- 19.4%
- ROCE
- 26.1%
- Dividend yield
- 0.23%
- 52w high / low
- 693/325
Metrics as of 6 Oct 2026. Not real time.
Track Blue Jet Healthcare Ltd
Cruxal reads every Blue Jet Healthcare Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Blue Jet Healthcare Ltd growth and returns
- 10 Years
- %
- 5 Years
- 14%
- 3 Years
- 10%
- TTM
- -28%
- 10 Years
- %
- 5 Years
- 11%
- 3 Years
- 15%
- TTM
- -34%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- 1 Year
- -22%
- 10 Years
- %
- 5 Years
- 26%
- 3 Years
- 24%
- Last Year
- 19%
Blue Jet Healthcare Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹293 cr, down 17.5% from ₹355 cr a year earlier. Net profit was ₹78 cr, down 14.3% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 208 | 318 | 340 | 355 | 165 | 192 | 235 | 293 |
| Expenses | 139 | 194 | 200 | 234 | 111 | 146 | 163 | 195 |
| Operating profit | 69 | 124 | 140 | 121 | 55 | 47 | 71 | 98 |
| OPM % | 33% | 39% | 41% | 34% | 33% | 24% | 30% | 33% |
| Other income | 12 | 13 | 12 | 8 | 24 | 13 | 23 | 15 |
| Interest | 0 | 0 | 0 | 1 | 5 | 0 | 1 | 1 |
| Depreciation | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 7 |
| Profit before tax | 77 | 132 | 147 | 123 | 69 | 54 | 87 | 106 |
| Tax % | 24% | 25% | 25% | 26% | 24% | 25% | 26% | 26% |
| Net profit | 58 | 99 | 110 | 91 | 52 | 40 | 64 | 78 |
| EPS (₹) | 3.36 | 5.71 | 6.35 | 5.26 | 3.01 | 2.32 | 3.71 | 4.51 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Blue Jet Healthcare Ltd annual results
| ₹ crore | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 538 | 499 | 683 | 721 | 712 | 1,030 | 947 | 886 |
| Operating profit | 214 | 207 | 249 | 219 | 231 | 378 | 294 | 271 |
| OPM % | 40% | 41% | 36% | 30% | 32% | 37% | 31% | 31% |
| Net profit | 145 | 142 | 182 | 160 | 164 | 305 | 248 | 235 |
| EPS (₹) | 24,118.33 | 1,428.77 | 10.47 | 9.23 | 9.44 | 17.59 | 14.29 | 13.55 |
TTM is the trailing twelve months to the most recent quarter.
Blue Jet Healthcare Ltd balance sheet
| ₹ crore | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity capital | 0.60 | 10 | 35 | 35 | 35 | 35 | 35 |
| Reserves | 198 | 330 | 487 | 647 | 811 | 1,098 | 1,325 |
| Borrowings | 74 | 52 | 19 | 5 | 3 | 21 | 44 |
| Other liabilities | 92 | 142 | 173 | 176 | 211 | 263 | 238 |
| Total liabilities | 364 | 534 | 713 | 862 | 1,059 | 1,418 | 1,641 |
| Fixed assets | 107 | 139 | 156 | 151 | 172 | 300 | 316 |
| CWIP | 2 | 3 | 3 | 30 | 147 | 89 | 301 |
| Investments | 26 | 37 | 94 | 189 | 250 | 187 | 252 |
| Other assets | 229 | 355 | 460 | 491 | 489 | 841 | 771 |
| Total assets | 364 | 534 | 713 | 862 | 1,059 | 1,418 | 1,641 |
As reported by the company. Total assets equal total liabilities by construction.
Blue Jet Healthcare Ltd cash flow
| ₹ crore | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Cash from operations | 122 | 137 | 146 | 142 | 241 | 46 | 334 |
| Cash from investing | -45 | -61 | -76 | -147 | -264 | -35 | -276 |
| Cash from financing | -72 | -21 | -56 | -4 | -2 | -19 | -31 |
| Net cash flow | 5 | 55 | 14 | -10 | -24 | -8 | 28 |
| Free cash flow | 106 | 85 | 125 | 83 | 68 | -34 | 115 |
| CFO / operating profit | 80% | 66% | 70% | 92% | 109% | 36% | 151% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Blue Jet Healthcare Ltd operating ratios
| Per year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| ROCE % | — | 58% | 53% | 35% | 30% | 40% | 26% |
| Debtor days | 80 | 105 | 121 | 121 | 91 | 124 | 131 |
| Inventory days | 120 | 253 | 133 | 137 | 151 | 209 | 157 |
| Days payable | 90 | 128 | 72 | 58 | 35 | 70 | 48 |
| Cash conversion cycle | 110 | 231 | 183 | 199 | 206 | 262 | 240 |
| Working capital days | 55 | 89 | 103 | 120 | 92 | 157 | 136 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Blue Jet Healthcare Ltd shareholding pattern
Promoters held 73.15% at Jul 2026, down from 79.81% at Sep 2025. FIIs 0.63% and DIIs 9.11%.
| % held | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Jul 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 86.00% | 86.00% | 86.00% | 79.81% | 79.81% | 79.81% | 79.81% | 73.15% |
| FIIs | 1.10% | 2.28% | 1.97% | 1.83% | 1.14% | 0.89% | 0.40% | 0.63% |
| DIIs | 2.02% | 1.33% | 0.95% | 3.63% | 4.65% | 4.51% | 4.65% | 9.11% |
| Public | 10.87% | 10.38% | 11.08% | 14.74% | 14.41% | 14.80% | 15.14% | 17.11% |
| No. of shareholders | 43,003 | 54,581 | 70,772 | 80,117 | 80,187 | 79,199 | 78,917 | 78,927 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Blue Jet Healthcare Ltd corporate filings
- Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September, 2026Company Updatelow impact
- Intimation of closure of trading windowInsider Trading / SASTlow impact
- Blue Jet Healthcare Limited Announces Successful Conclusion of 58th AGM and Approval of DividendAGM/EGMlow impact
Cruxal's analysis: Blue Jet Healthcare Limited has successfully concluded its 58th Annual General Meeting…
Read the full analysis - Blue Jet Healthcare Limited concludes 58th Annual General Meeting; declares dividend of INR 1.20 per shareAGM/EGMlow impact
Cruxal's analysis: Blue Jet Healthcare Limited has successfully concluded its 58th Annual General Meeting…
Read the full analysis - Blue Jet Healthcare Ltd announces 58th Annual General Meeting via VC/OAVMCompany Updatelow impact
Cruxal's analysis: Blue Jet Healthcare Ltd has issued a mandatory newspaper publication regarding the…
Read the full analysis - Blue Jet Healthcare Ltd files Business Responsibility and Sustainability Report (BRSR) for FY 2025-26Otherslow impact
Cruxal's analysis: Blue Jet Healthcare Ltd has submitted its Business Responsibility and Sustainability…
Read the full analysis - Blue Jet Healthcare Limited Announces 58th AGM Notice, Final Dividend of INR 1.20 per share, and Key Management Re-appointmentsAGM/EGMlow impact
Cruxal's analysis: Blue Jet Healthcare Limited has issued the notice for its 58th Annual General Meeting…
Read the full analysis - Blue Jet Healthcare Ltd releases Annual Report for FY 2025-26Otherslow impact
Cruxal's analysis: Blue Jet Healthcare Ltd has filed its Annual Report for the financial year 2025-26. The…
Read the full analysis - Blue Jet Healthcare Ltd schedules 58th Annual General Meeting for September 21, 2026Company Updatelow impact
Cruxal's analysis: Blue Jet Healthcare Ltd has issued a formal notice regarding its 58th Annual General…
Read the full analysis - Blue Jet Healthcare Q1 FY27 Earnings Call: Revenue of INR 293 crore with Strong Operational Momentum and Strategic Capex ProgressCompany Updatehigh impact
Cruxal's analysis: Blue Jet Healthcare reported Q1 FY27 revenue of INR 293 crore, reflecting a 25%…
Read the full analysis - Blue Jet Healthcare Reports Robust Q1 FY27 Standalone Performance with Over 30% YoY Growth in Revenue and Net ProfitCompany Updatehigh impact
Cruxal's analysis: Blue Jet Healthcare Limited has announced strong standalone financial results for the…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.